Feed / COLL

Collegium Pharmaceutical, Inc.

COLL

Healthcare · 28.73 -17.5% today

Isolated · not yet confirmedMarket checked 19 Aug, 15:55 GMT-4

Jodie situation report

Collegium Pharmaceutical, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.

Company-17.5% todayVolume comparison unavailable
Market group0 of 1 activePain Management Pharmaceuticals · unavailable
Disclosed network0 of 7 confirmingNo filing-linked name is confirming now
What would change this read
  • COLL's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if COLL's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind COLL

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

TMOThermo Fisher Scientific IncsupplierFeb 26, 2026

To date, we have produced Xtampza ER through a contract manufacturing organization, Patheon, a subsidiary of Thermo Fisher Scientific, pursuant to a third-party supply agreement.

SGIOFFiling-linked namepartnerMay 7, 2026

We are party to a license agreement with Grünenthal Gmbh (the “Grünenthal License”) pursuant to which we license the right to commercialize the Nucynta Products in the United States and its territories and a license agreement with Shionogi (the “Shionogi Lice…

TAKTakeda Pharmaceutical Company LimitedpartnerFeb 26, 2026

Tupper held several roles of increasing responsibility at Shire Pharmaceuticals (acquired by Takeda in 2019) including Vice President, U.S.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

COLL is currently a Leader in the organic co-movement group Pain Management Pharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for COLL; it is not active in the latest market snapshot.